Prevalence and Predictors of Poor BMD Gains to Romosozumab: A Real-World Prospective Multicenter Study in Switzerland

Evenity (romosozumab-aqqg) - Astellas, Amgen, UCB

https://asbmr.confex.com/asbmr/2026/meetingapp.cgi/Paper/7791

Serge Livio Ferrari, MD 1; Magaly Hars 1; Justine Falciola 2; Olivier Lamy 3; Christian Meier 4; Sigrid Jehle-Kunz 5; Bérengère Aubry-Rozier 6; Emmanuel Biver 1; Elena Gonzalez Rodriguez, PhD, MD 7

Aug 24, 2026